ConductScience.org, home

Gene · 713

C1QB: complement C1q B chain

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. C1QB: complement C1q B chain. Genes, record 713. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/713

On this page

Gene

Symbol
C1QB
HGNC
Name
complement C1q B chain
HGNC
NCBI Gene ID
713
NCBI Gene
HGNC ID
HGNC:1242
HGNC
Ensembl
ENSG00000173369
NCBI Gene
Aliases
C1QD2
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
P02746Complement C1q subcomponent subunit B25311GeneID, HGNC

Source UniProt

Patents97

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
JP 2026028257 A2026-02-192P02746Espacenet
US 12534522 B22026-01-272P02746Espacenet
JP 2026004568 A2026-01-1441962P02746Espacenet
EP 4670793 A12025-12-317P02746Espacenet
EP 4650780 A22025-11-194933P02746Espacenet
JP 2025533847 A2025-10-0923P02746Espacenet
JP 2025147176 A2025-10-061776P02746Espacenet
JP 2025529142 A2025-09-045655P02746Espacenet
WO 2025165658 A12025-08-0734P02746Espacenet
US 12371689 B22025-07-295655P02746Espacenet

1 to 10 of 97

See all 97 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants1,457

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleC1QB papersNewest fiscal year
P30CA008748Cancer Center Support Grant92025
P30CA091842Cancer Center Support Grant52025
P51OD011132Emory National Primate Research Center52025
UL1TR001863Yale Clinical and Translational Science Award52025
P30CA016672Cancer Center Support Grant42025
T32AI007290Molecular and Cellular Immunobiology42025
U19AI057266Vaccine and Infection Induced Immunity in the Young and Aged42025
P30CA014195Cancer Center Support Grant (CCSG)32025
P30CA033572Cancer Center Support Grant32025
P30CA046592University of Michigan Rogel Cancer Center Support Grant 2023-202832025

1 to 10 of 1,457Source NIH's project files

See all 1,457 nih grants

Papers1,828

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Multi-omics analyses demonstrate complement dysregulation is involved in focal segmental glomerulosclerosis.Front Immunol202642780117PubTator, text miningPubMed
Nocardia lung infection in severe asthma with immune dysfunction.J Asthma202642742958PubTator, text miningPubMed
An Investigation to Study Morphology, Nanomechanical Attributes, Transcriptomics, and Proteomics of Tumor Associated Macrophages Derived Extracellular Vesicles in the Tumor Microenvironment.J Anal Oncol202642719843PubTator, text miningPubMed
Proteomic profiling of cephalic vein reveals potential biomarkers for arteriovenous fistula neointimal hyperplasia in ESRD patients.Ren Fail202642703036PubTator, text miningPubMed
Complement Activation Linked to Type II Interferon Signaling in Still Disease.Arthritis Rheumatol202642640011PubTator, text miningPubMed
Comparative assessment of host transcriptomic- and bacteriological- markers for monitoring treatment response among active tuberculosis patients: a longitudinal study.Int J Infect Dis202642419448PubTator, text miningPubMed
Exploring shared biomarkers and their mechanisms in thyroid cancer and systemic lupus erythematosus via bioinformatics analysis.Discov Oncol202642348043PubTator, text miningPubMed
Integrated Transcriptomic Analysis Suggests a C1Q-Related Macrophage-Fibroblast Signaling Axis in Keloids.Int J Mol Sci202642278663PubTator, text miningPubMed
Genetic landscape of early-onset systemic lupus erythematous in India.Rheumatology (Oxford)202642251732PubTator, text miningPubMed
Exploration of common immune mechanisms and hub genes in latent and active tuberculosis infection.Front Cell Infect Microbiol202642245998PubTator, text miningPubMed

1 to 10 of 1,828

See all 1,828 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/713

GET https://conductscience.org/api/genes/v1/713/patents?page=2